Skip to main content
. 2025 Mar 3;15:7490. doi: 10.1038/s41598-025-88810-x

Table 1.

Survival and clinicopathological characteristics of study cohort.

Training cohort Testing cohort
N Median(std/range) N Median(std/range)
Patient included 257 - 367 -
Follow-up time (month) - 30.4(21.5) - 52.7(26.0)
1 year progression 25 - 51 -
3 years progression 51 - 91 -
5 years progression 57 - 111 -
Progression time (month) - 13.7 - 13.2
1 year LR 7 - 18 -
3 years LR 20 - 27 -
5 years LR 22 - 39 -
LR Time (month) - 12.3 - 13.7
1 year RR 7 - 18 -
3 years RR 15 - 25 -
5 years RR 17 - 29 -
RR time (month) - 14.6 - 9.4
1 year DM 17 - 23 -
3 years DM 31 - 50 -
5 years DM 32 - 57 -
DM time (month) - 10.3 - 13.5
1 year RIP 11 - 9 -
3 years RIP 23 - 18 -
5 years RIP 30 - 29 -
RIP time (month) - 18.1 - 26
Male 204 - 273 -
Female 53 - 94 -
T1/T2 116 - 45 -
T3/T4 141 - 322 -
N0/N1 104 - 47 -
N2/N3 154 - 320 -
RT alone 25 - 53 -
CCRT 232 - 313 -
Induction chemo 98 - 48 -
w/o induction chemo 159 - 319 -
Adjuvant chemo 90 - 72 -
w/o adjuvant chemo 167 - 295 -
ECOG = 0 33 - 109 -
ECOG = 1 224 - 258 -
EBV DNA positive 198 - 294 -
EBV DNA negative 59 - 73 -
Age - 54(18–86) - 54(20–89)
Body height (m) - 1.66(1.38–1.89) - 1.65(1.41–1.84)
1st recorded BW (kg) 257 65.8(38.5–145.6) 367 61.7(33.4–105.1)
Time from RT start (day) - 0 - 0
2nd recorded BW (kg) 257 64.2(38.5–145.6) 367 61.7(33.4–105.1)
Time from RT start (day) - 7(3–11) - 7(2–16)
3rd recorded BW (kg) 257 64.6(37.8–145.3) 367 61.0(35.5–105.5)
Time from RT start (day) - 14(10–18) - 14(7–23)
4th recorded BW (kg) 255 63.6(37.3–145.2) 365 60.0(34.1–103.6)
Time from RT start (day) - 21(17–28) - 21(11–29)
5th recorded BW (kg) 255 61.6(36.5–145.3) 363 58.5(33–100.3)
Time from RT start (day) - 28(24–31) - 28(21–36)
6th recorded BW (kg) 252 61.0(35.2–143.7) 331 57.8(32.1–98.0)
Time from RT start (day) - 35(31–42) - 35(27–45)
7th recorded BW (kg) 252 60.3(35.4–142.8) 155 56.0(31–95.8)
Time from RT start (day) - 42(37–51) - 42(35–50)